Age-adjusted baseline D-dimer predicts thrombotic events during readmission in anticoagulated patients with non-valvular atrial fibrillation

Abstract Background Patients with non-valvular atrial fibrillation (NVAF) remain at substantial risk of thrombotic and bleeding events despite oral anticoagulation, and readmission is a common and costly consequence. D-dimer reflects persistent coagulation and fibrinolysis activation and has been associated with adverse outcomes in atrial fibrillation, but whether a single baseline measurement can predict events during readmission remains unclear. Methods We retrospectively studied 1,108 anticoagulated patients with NVAF who had multiple hospitalisations at our institution between 2018 and 2022. Patients were stratified by baseline D-dimer according to an age-adjusted cut-off. The primary endpoint was a composite of thrombotic events, major bleeding and death during readmission, adjudicated by a hierarchical first-event rule. Multivariable Cox regression was performed in the 899 patients with complete CHA₂DS₂-VASc and HAS-BLED scores. Sensitivity analyses included propensity score matching (230 pairs) and a competing-risk model and a 30-day landmark analysis. The incremental value of the age-adjusted D-dimer cut-off beyond CHA₂DS₂-VASc was assessed by the C-statistic. Results The abnormal-D-dimer group had a higher incidence of the composite endpoint (24.0% vs 9.6%, P < 0.001) and of thrombotic events (19.7% vs 8.2%, P < 0.001). Abnormal D-dimer independently predicted the composite endpoint (adjusted HR 1.64, 95% CI 1.09–2.47) and thrombotic events (adjusted HR 2.02, 95% CI 1.30–3.15), but not major bleeding (HR 1.46, 95% CI 0.44–4.90) or death during readmission (HR 1.73, 95% CI 0.54–5.52). Sensitivity analyses were consistent for the composite and thrombotic endpoints, whereas bleeding and death events were too few for reliable estimates. Adding D-dimer to CHA₂DS₂-VASc improved discrimination (ΔC = 0.034, 95% CI 0.006–0.076) and reclassification (24-month NRI = 43.8%; IDI = 0.025). Conclusions In anticoagulated patients with NVAF, a baseline D-dimer above the age-adjusted cut-off independently predicts thrombotic events during subsequent readmission and provides incremental predictive information beyond CHA₂DS₂-VASc.

Authors

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11220651/v1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Age-adjusted baseline D-dimer predicts thrombotic events during readmission in anticoagulated patients with non-valvular atrial fibrillation

Jingdan Yu, Xiaosu Wang, Li Zhang, Dan Zhang et al.
1 links
Research Square
Atrial Fibrillation Management and Outcomes
preprint

Age-adjusted baseline D-dimer predicts thrombotic events during readmission in anticoagulated patients with non-valvular atrial fibrillation

Jingdan Yu, Xiaosu Wang, Li Zhang, Dan Zhang, Qichao Li, Zheng Dai, Xinsheng Yan
preprint en

Abstract

Abstract Background Patients with non-valvular atrial fibrillation (NVAF) remain at substantial risk of thrombotic and bleeding events despite oral anticoagulation, and readmission is a common and costly consequence. D-dimer reflects persistent coagulation and fibrinolysis activation and has been associated with adverse outcomes in atrial fibrillation, but whether a single baseline measurement can predict events during readmission remains unclear. Methods We retrospectively studied 1,108 anticoagulated patients with NVAF who had multiple hospitalisations at our institution between 2018 and 2022. Patients were stratified by baseline D-dimer according to an age-adjusted cut-off. The primary endpoint was a composite of thrombotic events, major bleeding and death during readmission, adjudicated by a hierarchical first-event rule. Multivariable Cox regression was performed in the 899 patients with complete CHA₂DS₂-VASc and HAS-BLED scores. Sensitivity analyses included propensity score matching (230 pairs) and a competing-risk model and a 30-day landmark analysis. The incremental value of the age-adjusted D-dimer cut-off beyond CHA₂DS₂-VASc was assessed by the C-statistic. Results The abnormal-D-dimer group had a higher incidence of the composite endpoint (24.0% vs 9.6%, P < 0.001) and of thrombotic events (19.7% vs 8.2%, P < 0.001). Abnormal D-dimer independently predicted the composite endpoint (adjusted HR 1.64, 95% CI 1.09–2.47) and thrombotic events (adjusted HR 2.02, 95% CI 1.30–3.15), but not major bleeding (HR 1.46, 95% CI 0.44–4.90) or death during readmission (HR 1.73, 95% CI 0.54–5.52). Sensitivity analyses were consistent for the composite and thrombotic endpoints, whereas bleeding and death events were too few for reliable estimates. Adding D-dimer to CHA₂DS₂-VASc improved discrimination (ΔC = 0.034, 95% CI 0.006–0.076) and reclassification (24-month NRI = 43.8%; IDI = 0.025). Conclusions In anticoagulated patients with NVAF, a baseline D-dimer above the age-adjusted cut-off independently predicts thrombotic events during subsequent readmission and provides incremental predictive information beyond CHA₂DS₂-VASc.

Research Square
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon